Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2012-10-31
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method and material Randomized, controlled, multi-center, investigator-blinded study. A minimum of 56 patients (2X28 umbi/epi) are included, inclusion number is based on power calculations. Patients are randomized either to abdominal binder or no abdominal binder. The abdominal binder is worn from immediately after the operation and continuously for 7 days, night and day. Outcomes are based on patient self-reported registrations using Visual Analog Scales (VAS) and Carolina Comfort Scale (CCS), which is a validated, hernia-specific tool to estimate quality of life, pain and discomfort. Patients are followed-up for 30 days. For secondary outcome we use ultrasound to measure the volume of seroma formation. We use Mann-Witney, non-parametric statistics calculating the seroma formation and Friedmanns test for pain, discomfort and quality of life for the effect of time on inter- and intragroup differences during the study period. P \< 0.05 is considered significant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Postoperative Abdominal Binder to Improve Outcomes After Incisional Hernia Repair
NCT01776775
Comparing Pain After Laparoscopic Hernia Repair Using Two Different Types of Mesh Fixation
NCT02467140
Mesh Type in Ventral Hernia Repair
NCT03091790
AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair
NCT00749268
Prospective Study Of A Size Tailored Approach To Repair Umbilical And Epigastric Primary Ventral Hernias
NCT01639118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
abdominal binder
The abdominal binder is worn from immediately after the operation and continuously for 7 days, night and day. The belts are standard elastic belts (ostomy belts) from "ETO garments©" with standard height of 22 cm. and five different sizes in width (S, M, L, XL, XXL- depending on waist measure). A fitting will be done before the operation by waist measurement according to the recommendation from the company.
ETO garments
patients wearing abdominal binder for 7 days postoperatively
no abdominal binder
no abdominal binder
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ETO garments
patients wearing abdominal binder for 7 days postoperatively
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fascia defects 2-8 cm measured preoperatively by the surgeon at the out-patient clinic for umbi/epi
* Elective, primary and recurrent laparoscopic trocar-site hernia
* Patients between 18-80 years
Exclusion Criteria
* Expected low compliance (language problems, dementia and abuse etc.)
* Fascia defects \>8 cm at the preoperative clinical examination.
* Acute operation
* Chronic pain syndrome
* Decompensated liver cirrhosis (Child-Pugh B-C)
* Patients with a stoma
* If a secondary operation is performed during the hernia repair procedure
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Copenhagen University Hospital at Herlev
OTHER
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mette Willaume Christoffersen
MD, PhD. stud.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thue Bisgaard, MD
Role: STUDY_DIRECTOR
University Hospital HVidovre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hvidovre Hospital
Hvidovre, CPH, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AB-BINDER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.